stockrow
Friday 6 November 2026
Export FOCL’s income statement to Excel — free account
FocalTherics
FOCL Healthcare Medical Distribution
- Revenue
- +38.9%
- EPS
- −129.4%
- Free cash flow
- +21.5%
- Total debt
- +366.8%
Quarter to June 2026, against a year earlier
3.66
0.59
−13.88%
Follow FOCL
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.39 | 1.75 | 1.88 | 2.50 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(21.77) | (50.84) | (46.92) | (52.67) | |
P/B ratio |
2.02 | 6.35 | 13.80 | 0.00 | |
Price to Tangible BV |
2.16 | 7.31 | 24.87 | 0.00 | |
EV/Sales |
1.30 | 1.78 | 2.01 | 2.74 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(5.73) | (7.63) | (10.62) | (16.35) | |
EV/FCF |
(4.15) | (5.40) | (7.15) | (11.13) | |
Quick Ratio |
0.94 | 0.99 | 0.94 | 0.88 | |
Current Ratio |
1.41 | 1.54 | 1.34 | 1.60 | |
Net Debt/EBITDA |
0.92 | (0.34) | (1.50) | (2.64) | |
Debt/Assets |
9.85% | 28.46% | 34.34% | 53.79% | |
Debt/Equity |
0.26 | 1.16 | 2.45 | (12.43) | |
Asset Turnover |
0.77 | 0.84 | 0.97 | 1.00 | |
Operating CF/Net income |
0.68 | 0.25 | 0.33 | 0.25 | |
Capex/Depreciation |
0.00 | (0.51) | (1.04) | (1.25) | |
Research and Development Expense of Revenue |
15.03% | 7.72% | 14.58% | 17.55% | |
Selling, General and Administrative Expense of Revenue |
63.49% | 51.87% | 72.51% | 98.87% | |
Intangible Assets out of Total Assets |
0.04 | 0.03 | 0.06 | 0.03 | |
Share Based Compensation of Revenue |
0.00% | 8.36% | 1.70% | 6.48% | |
Graham Net Nets |
0.09 | (0.02) | (0.08) | (0.10) | |
Graham Number |
0.00 | 0.00 | 0.00 | 1.41 | |
Earnings Yield |
(24.89%) | (23.40%) | (21.77%) | (19.88%) | |
Free Cash Flow Yield |
(22.61%) | (18.82%) | (14.97%) | (9.84%) | |
Revenue per Share |
0.43 | 0.82 | 0.48 | 0.35 | |
Operating CF per Share |
(0.11) | (0.06) | (0.08) | (0.10) | |
Capex per Share |
(0.05) | (0.05) | (0.02) | (0.03) | |
Free Cash Flow per Share |
(0.16) | (0.11) | (0.10) | (0.13) | |
Cash per Share |
0.33 | 0.55 | 0.40 | 0.57 | |
Shareholders Equity per Share |
0.73 | 0.52 | 0.27 | (0.09) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.73 | 0.52 | 0.27 | (0.09) | |
Free Cash Flow |
(5.92) | (4.17) | (3.90) | (4.95) | |
Working Capital |
15.19 | 20.02 | 12.86 | 22.17 | |
Capital Expenditures |
(1.98) | (1.75) | (0.93) | (1.25) | |
Net Current Asset Value |
7.29 | (2.42) | (11.59) | (18.76) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.12 | 0.06 | 0.05 | 0.10 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
20.18 | 18.66 | 18.91 | 16.26 | |
Average Payables |
20.37 | 11.43 | 15.63 | 16.09 | |
Average Inventory |
19.80 | 13.49 | 16.40 | 13.27 | |
Average Assets |
80.11 | 84.20 | 76.50 | 77.49 | |
Average Common Equity |
— | 47.93 | 36.86 | 29.19 |
Columns are period end dates · fundamentals updated 26 Oct 2026